The primary object of this study is to evaluate the efficacy and safety of 6 weeks of nebivolol monotherapy compared with placebo in patients with systolic stage 2 hypertension.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
433
Change From Baseline in Mean Seated Systolic Blood Pressure After 6 Weeks of Nebivolol Monotherapy
Office blood pressure measured at trough by automatic oscillometric device.
Time frame: Change from Baseline Visit 1 (week 0) to Visit 4 (Week 6)
Change From Baseline in Mean Seated Diastolic Blood Pressure After 6 Weeks of Nebivolol Monotherapy
Office blood pressure measured at trough by automatic oscillometric device.
Time frame: Change from Baseline (Week 0) to Visit 4 (Week 6)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Forest Investigative Site 008
Foley, Alabama, United States
Forest Investigative Site 021
Montgomery, Alabama, United States
Forest Investigative Site 006
Chino, California, United States
Forest Investigative Site 002
Long Beach, California, United States
Forest Investigative Site 004
Los Angeles, California, United States
Forest Investigative Site 020
Temecula, California, United States
Forest Investigative Site 028
Coral Gables, Florida, United States
Forest Investigative Site 014
Daytona Beach, Florida, United States
Forest Investigative Site 001
Fort Lauderdale, Florida, United States
Forest Investigative Site 037
Fort Lauderdale, Florida, United States
...and 26 more locations